✦ LIBER ✦
O-188 Encouraging activity and durable responses demonstrated by the epithelial growth factor receptor-tyrosine kinase inhibitor, Erlotinib (Tarceva TM, OSI774), in patients with advanced bronchioloalveolar (BAC) cell carcinoma
✍ Scribed by Patel, Jyoti D.; Miller, Vincent A.; Kris, Mark G.; Shah, Neelam T.; Pizzo, Barbara; Tyson, Leslie; Zakowski, Maureen; Memoli, Natalie; Heelan, Robert; Johnson, David H.
- Book ID
- 118571578
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- English
- Weight
- 187 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0169-5002
No coin nor oath required. For personal study only.